Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,529,137
+$149,561 QoQ
Shares Held
19,682
-0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#1,447
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kendall Capital Management holds $22,925,368 across 11 Drug Manufacturers - General names. MRK ranks #4 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
24,818 | $6,245,201 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
69,150 | $3,984,423 | |
| 3 | GSK |
GSK plc
|
50,941 | $2,670,327 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
19,682 | $2,529,137 | |
| 5 | JNJ |
Johnson & Johnson
|
8,136 | $2,066,299 | |
| 6 | PFE |
Pfizer Inc
|
49,545 | $1,193,043 | |
| 7 | AMGN |
Amgen Inc
|
2,995 | $1,084,549 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,362 | $1,056,455 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,529,137 | 19,682 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,379,576 | 19,782 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,979,624 | 18,807 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $1,600,964 | 19,075 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,400,498 | 17,692 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,692,604 | 18,857 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,924,838 | 19,349 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,246,784 | 19,785 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,346,629 | 18,955 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,361,905 | 17,900 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,030,497 | 18,625 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $1,959,138 | 19,030 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,209,141 | 19,145 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,987,897 | 18,685 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,087,857 | 18,818 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $1,681,493 | 19,525 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $1,732,959 | 19,008 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,528,837 | 18,633 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,351,776 | 17,638 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,219,636 | 16,238 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,177,282 | 15,138 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $920,686 | 11,943 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $842,785 | 10,303 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $721,914 | 8,703 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $488,571 | 6,318 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $363,772 | 4,728 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||